结核菌素皮肤试验阳性的不孕患者妊娠与新生儿结局
该回顾性队列分析纳入2016年11月至2022年9月在山东大学附属生殖医院首次接受IVF/ICSI-ET的6283例不孕女性,均无既往结核或活动性结核。TST阳性组(1704例)与TST阴性组(4243例)的妊娠及新生儿结局无显著差异(P>0.05);TST(+++)亚组中,预防性抗结核治疗组(336例)与未治疗组(168例)的妊娠及新生儿结局也无显著差异(P>0.05)。
要点
- TST阳性与TST阴性不孕女性IVF/ICSI-ET后的妊娠及新生儿结局无显著差异(P>0.05)。
- TST(+++)患者中,预防性抗结核治疗组与未治疗组的妊娠及新生儿结局无显著差异(P>0.05)。
- 无既往结核或活动性结核的不孕女性,TST阳性及预防性抗结核治疗不影响IVF/ICSI-ET妊娠及新生儿结局。
核心结论
- 对于无既往结核或活动性结核、接受IVF/ICSI-ET的不孕女性,TST阳性及IVF/ICSI-ET前预防性抗结核治疗不影响妊娠或新生儿结局。
研究设计与样本
- 回顾性队列分析,纳入2016年11月至2022年9月在山东大学附属生殖医院首次接受IVF/ICSI-ET治疗的6283例不孕女性,均无既往结核或活动性结核。
- 从未接受预防性抗结核治疗的5947例按TST结果分为TST阳性组(1704例)和TST阴性组(4243例)。
- TST(+++)(以20 mm硬结阈值为判定标准)的504例按IVF/ICSI-ET前是否接受预防性抗结核治疗分为治疗组(336例)和未治疗组(168例)。
主要发现
- TST阳性组与TST阴性组的妊娠结局和新生儿结局均无显著差异(P>0.05)。
- TST(+++)亚组中,治疗组与未治疗组的妊娠结局和新生儿结局均无显著差异(P>0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Do infertile women with positive tuberculin skin test (TST) results have a higher risk of adverse pregnancy outcomes after IVF or intracytoplasmic sperm injection and embryo transfer (ICSI-ET) and does preventive anti-tuberculosis treatment applied to infertile women with positive TST results before IVF/ICSI-ET affect pregnancy and neonatal outcomes? DESIGN: This was a retrospective cohort analysis of 6283 infertile women who underwent IVF/ICSI-ET treatment for the first time at the Reproductive Hospital affiliated to Shandong University from November 2016 to September 2022. None of the participants had prior tuberculosis or active tuberculosis. According to their TST results, 5947 patients who had never received preventive anti-tuberculosis treatment were divided into a TST-positive group (1704 cases) and a TST-negative group (4243 cases). A total of 504 patients with TST (+++) results (using the 20 mm sclerosis threshold) were divided into a treated TST (+++) group (336 cases) and an untreated TST (+++) group (168 cases) according to whether they received preventive anti-tuberculosis treatment before IVF/ICSI-ET. The outcome measures were pregnancy outcomes and neonatal outcomes. RESULTS: There were no significant differences in pregnancy or neonatal outcomes between the TST-positive group and the TST-negative group (P > 0.05). In the TST (+++) group, there were no significant differences in pregnancy or neonatal outcomes between the treated TST (+++) group and the untreated TST (+++) group (P > 0.05). CONCLUSIONS: For infertile women undergoing IVF/ICSI-ET without prior tuberculosis or active tuberculosis, positive TST results and preventive anti-tuberculosis treatments prior to IVF/ICSI-ET do not affect pregnancy or neonatal outcomes.
引用
- Zang Z, Hu M, Yan Y, et al. Pregnancy and neonatal outcomes in infertile patients with positive tuberculin skin test results. Reprod Biomed Online. 2023. PMID: 37666021. doi:10.1016/j.rbmo.2023.103307
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。